133 related articles for article (PubMed ID: 7975366)
1. [Current possibilities in the therapy of iron overload].
Cermák J
Vnitr Lek; 1994 Sep; 40(9):605-8. PubMed ID: 7975366
[TBL] [Abstract][Full Text] [Related]
2. Iron chelation therapy.
Hoffbrand AV; Wonke B
J Intern Med Suppl; 1997; 740():37-41. PubMed ID: 9350180
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of iron overload states with oral administration of the chelator agent, L1 (Deferiprone)].
Cermák J; Brabec V
Vnitr Lek; 1994 Sep; 40(9):586-90. PubMed ID: 7975362
[TBL] [Abstract][Full Text] [Related]
4. Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias.
Kwiatkowski JL; Cohen AR
Hematol Oncol Clin North Am; 2004 Dec; 18(6):1355-77, ix. PubMed ID: 15511620
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
Schafer AI; Rabinowe S; Le Boff MS; Bridges K; Cheron RG; Dluhy R
Arch Intern Med; 1985 Jul; 145(7):1217-21. PubMed ID: 3925909
[TBL] [Abstract][Full Text] [Related]
6. Iron-chelating therapy.
Hershko C; Weatherall DJ
Crit Rev Clin Lab Sci; 1988; 26(4):303-45. PubMed ID: 3077034
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone: new preparation. Poorly assessed.
Prescrire Int; 2000 Oct; 9(49):131-5. PubMed ID: 11603411
[TBL] [Abstract][Full Text] [Related]
8. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Sidi Y; Shaklai M; Liban E; Pinkhas J
Isr J Med Sci; 1981 May; 17(5):348-51. PubMed ID: 7263191
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and therapy of iron overload with desferrioxamine].
Andres J; Stobbe H
Z Gesamte Inn Med; 1984 Apr; 39(8):167-9. PubMed ID: 6730593
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of iron-chelating agents in cultured heart muscle cells. Identification of a potential drug for chelation therapy.
Sciortino CV; Byers BR; Cox P
J Lab Clin Med; 1980 Dec; 96(6):1081-5. PubMed ID: 7430764
[TBL] [Abstract][Full Text] [Related]
11. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
[TBL] [Abstract][Full Text] [Related]
12. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
Kontoghiorghes GJ
Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
[TBL] [Abstract][Full Text] [Related]
13. Management of iron overload in the pediatric patient.
Cohen A
Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185
[TBL] [Abstract][Full Text] [Related]
14. [Long-term treatment of patients with transfusion hemosiderosis using oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1)].
Goudsmit R
Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2133-6. PubMed ID: 1944690
[TBL] [Abstract][Full Text] [Related]
15. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
Kontoghiorghes GJ; Sheppard L; Chambers S
Arzneimittelforschung; 1987 Oct; 37(10):1099-102. PubMed ID: 3435580
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
Kontoghiorghes GJ
Toxicol Lett; 1995 Oct; 80(1-3):1-18. PubMed ID: 7482575
[TBL] [Abstract][Full Text] [Related]
17. Dose response studies using desferrioxamine and orally active chelators in a mouse model.
Kontoghiorghes GJ
Scand J Haematol; 1986 Jul; 37(1):63-70. PubMed ID: 3764334
[TBL] [Abstract][Full Text] [Related]
18. The selection and evaluation of new chelating agents for the treatment of iron overload.
Pitt CG; Gupta G; Estes WE; Rosenkrantz H; Metterville JJ; Crumbliss AL; Palmer RA; Nordquest KW; Hardy KA; Whitcomb DR; Byers BR; Arceneaux JE; Gaines CG; Sciortino CV
J Pharmacol Exp Ther; 1979 Jan; 208(1):12-8. PubMed ID: 759605
[TBL] [Abstract][Full Text] [Related]
19. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone.
Nielsen P; Fischer R; Engelhardt R; Tondüry P; Gabbe EE; Janka GE
Br J Haematol; 1995 Dec; 91(4):827-33. PubMed ID: 8547125
[TBL] [Abstract][Full Text] [Related]
20. Treatment of iron overload in adults with continuous parenteral desferrioxamine.
Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
Am J Med; 1977 Dec; 63(6):958-66. PubMed ID: 605917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
